trastuzumab

0:08:31

Trastuzumab (Herceptin) & Pertuzumab (Perjeta) for HER2+ Breast Cancer: A COMPLETE Guide

0:03:50

Herceptin (trastuzumab) for HER2-Positive Breast and Stomach Cancer

0:02:06

Trastuzumab Deruxtecan for Breast Cancer | NEJM

0:02:12

Trastuzumab Deruxtecan in HER2-Low Advanced Breast Cancer | NEJM

0:04:31

Study of Atezolizumab with Pertuzumab and Trastuzumab in HER2- Positive Metastatic Breast Cancer

0:03:38

Biosimilar Trastuzumab

0:02:19

Trastuzumab and cardiovascular disease risk – Video abstract [69641]

0:02:13

HER-2 conversion: a phenomenon in trastuzumab resistance

0:04:11

21 Medicine of the week: Trastuzumab

0:01:43

GASTHER2: trastuzumab for advanced gastric cancer

0:01:12

Trastuzumab deruxtecan in metastatic HER2+ breast cancer

0:07:45

Trastuzumab Emtansine in HER2+ Breast Cancer

0:05:59

Trastuzumab Deruxtecan for the Treatment of HER2+ Breast Cancer

0:02:04

Breast Cancer Chess Championship: Trastuzumab vs HER2 Receptor

0:00:51

Dr. Jhaveri on the Use of Trastuzumab Biosimilars in Breast Cancer

0:00:59

Trastuzumab deruxtecan in patients with breast cancer with brain metastases

0:13:09

EVERYTHING you need to know About Herceptin Treatment...

0:02:06

PHranceSCa: evaluating patient satisfaction with subcutaneous pertuzumab and trastuzumab treatment

0:01:05

Dr. Hamilton on the Optimal Duration of Trastuzumab in HER2+ Breast Cancer

0:01:10

Dr. Bunn on Data With Trastuzumab Deruxtecan in HER2-Mutant NSCLC

0:03:48

Dr Felipe Ades-O que é Herceptin (trastuzumab)?

0:04:01

Trastuzumab deruxtecan: a promising agent for treating HER2-low breast cancer?

0:00:54

Dr. Shah on the Trastuzumab Biosimilar in Gastric Cancer

0:08:13

Clinical usage of antibody: Herceptin (Antibody as breast cancer medicine)